LP
BMY icon

LMR Partners’s Bristol-Myers Squibb BMY Stock Holding History

LMR Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.1M Buy
+364,600
New +$21.3M 0.05% 193
2025
Q4 		– Sell
-278,000
Closed -$12.5M – 1533
2025
Q3 		$12.5M Buy
+278,000
New +$13M 0.06% 265
2025
Q2 		– Sell
-50,000
Closed -$3.05M – 1393
2025
Q1 		$3.05M Buy
+50,000
New +$2.91M 0.03% 553

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LMR Partners's BMY Position: Q1 2026 in Review

LMR Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.24% in Q1 2026, selling an estimated $700 and leaving 5,001 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

LMR Partners first reported a position in BMY in Q4 2014 and has held it in 21 quarters since. The position peaked at $13.5M in Q3 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LMR Partners held 5,001 shares of Bristol-Myers Squibb worth $303K as of Q1 2026.
  • LMR Partners sold 12 Bristol-Myers Squibb shares in Q1 2026, an estimated $700.
  • Bristol-Myers Squibb made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1141 holding.
  • LMR Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 21 quarters since.
  • LMR Partners's Bristol-Myers Squibb position peaked at $13.5M in Q3 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.